Literature DB >> 33611133

Long-term activation of hippocampal glial cells and altered emotional behavior in male and female adult rats after different neonatal stressors.

Luis Miguel Saavedra1, Martha Guadalupe Hernández-Velázquez2, Scarlette Madrigal2, Alejandra Ochoa-Zarzosa3, Luz Torner4.   

Abstract

Early life stress increases the risk of developing psychiatric diseases in adulthood. Severe neonatal infections can also contribute to the development of affective illnesses. Stress and infections both trigger the immediate activation of the neuroimmune system. We compared the long-term effects of neonatal single or combined stress-immune challenges on emotional behavior and glial cell responses in the hippocampus. Male and female Sprague Dawley rats were randomly allocated across four conditions: (1) control + vehicle; (2) maternal separation (MS, 3 h/day on postnatal days [PN] 1-14) + vehicle; (3) control + lipopolysaccharide (LPS, 0.5. mg/kg, PN14); (4) MS + LPS. The rats' behaviors were analyzed from PN120 in males and from PN150 in diestrous females. LPS, but not MS, increased anxiety-like behavior in male rats; however, in females, it increased with both challenges. Depressive-like behavior increased after MS-but not LPS-in males and females. Combined stressors increased depressive-like behavior in both sexes. All stressors promoted microglial activation in CA3 and hilus in males and females. MS and LPS increased the astrocytic density within the male hilus, but LPS only increased it in CA3. MS prevented the rise in astrocytic density with LPS. In females, MS reduced the astrocytic population of the hilus and CA3 areas. Taken together, the behavioral and glial cell responses to early life challenges are sex-dependent and cell-type specific. This suggests a sexual dimorphism in the nature of the adverse event faced. These results have implications for understanding the emergence of psychiatric illnesses.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anxiety; Astrocytes; Depression; Lipopolysaccharide; Maternal separation; Microglia

Mesh:

Substances:

Year:  2021        PMID: 33611133     DOI: 10.1016/j.psyneuen.2021.105164

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  6 in total

Review 1.  Oxytocin and microglia in the development of social behaviour.

Authors:  Alicia Gonzalez; Elizabeth A D Hammock
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2022-07-11       Impact factor: 6.671

Review 2.  Early Life Adversity and Neuropsychiatric Disease: Differential Outcomes and Translational Relevance of Rodent Models.

Authors:  Renée C Waters; Elizabeth Gould
Journal:  Front Syst Neurosci       Date:  2022-06-23

Review 3.  Traumatic Injury to the Developing Brain: Emerging Relationship to Early Life Stress.

Authors:  Kaila N Parker; Michael H Donovan; Kylee Smith; Linda J Noble-Haeusslein
Journal:  Front Neurol       Date:  2021-08-18       Impact factor: 4.003

4.  Electroacupuncture improves repeated social defeat stress-elicited social avoidance and anxiety-like behaviors by reducing Lipocalin-2 in the hippocampus.

Authors:  Yi-Hung Chen; Sheng-Yun Xie; Chao-Wei Chen; Dah-Yuu Lu
Journal:  Mol Brain       Date:  2021-09-26       Impact factor: 4.041

5.  Beyond New Neurons in the Adult Hippocampus: Imipramine Acts as a Pro-Astrogliogenic Factor and Rescues Cognitive Impairments Induced by Stress Exposure.

Authors:  Ana R Machado-Santos; Eduardo Loureiro-Campos; Patrícia Patrício; Bruna Araújo; Nuno Dinis Alves; António Mateus-Pinheiro; Joana Sofia Correia; Mónica Morais; João M Bessa; Nuno Sousa; Ana J Rodrigues; João Filipe Oliveira; Luísa Pinto
Journal:  Cells       Date:  2022-01-24       Impact factor: 6.600

6.  Folic Acid Attenuates Glial Activation in Neonatal Mice and Improves Adult Mood Disorders Through Epigenetic Regulation.

Authors:  Tiantian Zhao; Dong Wu; Jingyi Du; Guowei Liu; Guangyu Ji; Zixiao Wang; Fan Peng; Lajie Man; Wenjuan Zhou; Aijun Hao
Journal:  Front Pharmacol       Date:  2022-02-07       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.